Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. (Q55470691)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. |
scientific article published in January 2006 |
Statements
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. (English)
1 reference
Henry S Friedman
1 reference
Darell D Bigner
1 reference
Sridharan Gururangan
1 reference
Annick Desjardins
1 reference
Allan H Friedman
1 reference
David A Reardon
1 reference
Roger E McLendon
1 reference
Jeremy N Rich
1 reference
R Edward Coleman
1 reference
Jennifer A Quinn
1 reference
James J Vredenburgh
1 reference
James E Herndon
1 reference
James M Provenzale
1 reference
Michael Badruddoja
1 reference
Michael R Zalutsky
1 reference
Gamal Akabani
1 reference
Charles N Pegram
1 reference
Jeanette M Dowell
1 reference
Xiao-Guang Zhao
1 reference
Terence Z Wong
1 reference
1 January 2006
1 reference
24
1 reference
1
1 reference
115-122
1 reference